Please use this identifier to cite or link to this item:
Title: Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand
Authors: Morgan Marks
Patti E. Gravitt
Swati B. Gupta
Kai Li Liaw
Amha Tadesse
Esther Kim
Chailert Phongnarisorn
Virach Wootipoom
Pissimai Yuenyao
Charoen Vipupinyo
Somchai Sriplienchan
David D. Celentano
Keywords: Medicine
Issue Date: 15-Nov-2011
Abstract: Background.Women diagnosed with cervical cancer report longer duration and more recent use of combined oral contraceptives (COCs). It is unclear how COC use impacts risk of cervical carcinogenesis.Methods.We estimated the risk of new human papillomavirus (HPV) DNA detection and persistence among 1135 human immunodeficiency virus (HIV)-negative women aged 20-37 years from Thailand who were followed for 18 months at 6-month intervals. Type-specific HPV DNA, demographic information, hormonal contraceptive use, sexual behavior, genital tract coinfection, and Papanicolaou test results were assessed at baseline and each follow-up.Results.Women who reported current COC use during follow-up were less likely to clear HPV infection compared with nonusers, independent of sexual behavior, and Papanicolaou test diagnosis (AHR: 0.67 [95% CI:. 49-.93]). Similar associations were not observed among women reporting current use of depomedroxyprogesterone acetate (DMPA). Neither COC nor DMPA use was significantly associated with new HPV DNA detection.Conclusions.These data do not support the hypothesis that contraceptive use is associated with cervical cancer risk via increased risk of HPV acquisition. The increased risk of HPV persistence observed among current COC users suggests a possible influence of female sex hormones on host response to HPV infection. © The Author 2011.
ISSN: 00221899
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.